trans-2-Methyl-cyclohexancarbonsaeure | 15177-62-5

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 环羧酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: trans-2-Methyl-cyclohexancarbonsaeure
• 英文别名: trans-2-Methyl-cyclohexan-carbonsaeure-(1)；(1R,2R)-2-methylcyclohexane-1-carboxylic acid
• CAS: 15177-62-5
• 化学式: C₈H₁₄O₂
• 分子量: 142.198
• InChiKey: VSKXJRZPVDLHFY-RNFRBKRXSA-N

物化性质

• 熔点：
  170-172 °C
• 沸点：
  242.2±0.0 °C(Predicted)
• 密度：
  1.025±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  (+)-(1R,2S)-1-carboxy-2-methylcyclohexane 生成 trans-2-Methyl-cyclohexancarbonsaeure
  参考文献：
  名称：

  LENNON, P.;ROSENBLUM, M., J. AMER. CHEM. SOC., 1983, 105, N 5, 1233-1241

  摘要：

  DOI：

文献信息

• Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
  申请人：Oka Takahiro

  公开号：US20070049593A1

  公开（公告）日：2007-03-01

  The present invention relates to a tetracyclic fused heterocyclic compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.

  本发明涉及一种四环融合杂环化合物，其化学式为[I]，其中每个符号的定义如规范中所述，或其药学上可接受的盐，以及一种丙型肝炎病毒（HCV）聚合酶抑制剂和治疗丙型肝炎的药物，本发明的化合物表现出基于HCV聚合酶抑制活性的抗HCV活性，因此可用作预防或治疗丙型肝炎的药物。
• TETRACYCLIC FUSED HETEROCYCLIC COMPOUND AND USE THEREOF AS HCV POLYMERASE INHIBITOR
  申请人：Oka Takahiro

  公开号：US20120070409A1

  公开（公告）日：2012-03-22

  The present invention relates to a tetracyclic fused heterocyclic compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.

  本发明涉及一种四环融合杂环化合物，其表示为以下公式[I]，其中每个符号如规范中所定义，或其药学上可接受的盐，以及一种丙型肝炎病毒（HCV）聚合酶抑制剂和治疗丙型肝炎的药物，本发明的化合物基于HCV聚合酶抑制活性显示出抗HCV活性，可用作预防或治疗丙型肝炎的药物。
• HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS
  申请人：Gellman Samuel H.

  公开号：US20120021530A1

  公开（公告）日：2012-01-26

  Disclosed are isolated, unnatural polypeptides containing cyclically-constrained β-amino acid residues and cyclically-constrained γ-amino acid residues. The compounds are unnatural and because they contain rotationally constrained residues that are not amenable to enzymatic degradation, the compounds are useful to probe protein-protein and other large molecule interactions.

  本发明涉及一种孤立的、非天然的多肽，其中包含有环限制的β-氨基酸残基和环限制的γ-氨基酸残基。这些化合物是非天然的，因为它们包含有旋转限制的残基，不易于酶降解，因此这些化合物可用于探究蛋白质-蛋白质和其他大分子相互作用。
• Attractants for the Mediterranean fruit fly
  申请人：THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce

  公开号：EP0340971A2

  公开（公告）日：1989-11-08

  Novel attractants for the Mediterrean Fruit fly, "Medfly" comprise isomeric blends of Cl-C₅ alkyl esters of iodo-trans-2-methylcyclohexanecarboxylic acid.

  针对地中海果蝇的新型引诱剂由碘-反式-2-甲基环己烷羧酸的 Cl-C₅ 烷基酯异构体混合物组成。
• Epimerization of 2- or 4-substituted cyclohexanecarboxylic acids
  申请人：KATAYAMA SEIYAKUSYO CO. Ltd.

  公开号：EP0814073A1

  公开（公告）日：1997-12-29

  The present invention relates to a new method for obtaining a purity of about 93 % to 100 % of the trans form of 2- or 4-substituted cyclohexanecarboxylic acid or reactive derivatives thereof from the cis form or a mixture of the cis and trans forms by a single step, particularly, to a method for obtaining a purity of substantially 100 % of the trans form of 4-substituted cyclohexanecarboxylic acid.

  本发明涉及一种从顺式或顺式和反式的混合物中一步获得纯度约为 93 % 至 100 % 的反式 2-或 4-取代环己烷羧酸或其反应衍生物的新方法，特别是涉及一种获得纯度基本为 100 % 的反式 4-取代环己烷羧酸的方法。